(Q45213523)

10 December 2017

Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease (English)

1 reference

10 December 2017

S P Close

1

1 reference

10 December 2017

P J Elliott

series ordinal

2

1 reference

10 December 2017

A G Hayes

series ordinal

3

1 reference

10 December 2017

A S Marriott

series ordinal

4

1 reference

10 December 2017

1 January 1990

1 reference

10 December 2017

6

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

10 December 2017

102

1 reference

10 December 2017

295-300

1 reference

10 December 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02244093

10 December 2017

0 references

cites work

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02244093

Failure of SKF 38393-A to relieve parkinsonian symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02244093

Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson's disease?

21 January 2018

1 reference

12 December 2020

Connections of the median and dorsal raphe nuclei in the rat: an autoradiographic and degeneration study.

1 reference

12 December 2020

The catecholamine uptake blocker nomifensine protects against MPTP-induced parkinsonism in monkeys.

1 reference

12 December 2020

The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmoset

1 reference

12 December 2020

Activation of presynaptic α-noradrenaline receptors in rat brain by the potent dopamine-mimetic N, N-dipropyl-5,6-ADTN

1 reference

12 December 2020

Confusion, dementia and anticholinergics in Parkinson's disease

1 reference

12 December 2020

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

12 December 2020

Pargyline Prevents MPTP-Induced Parkinsonism in Primates

1 reference

12 December 2020

MK 458, a selective and potent D2 receptor agonist in advanced Parkinson's disease

1 reference

12 December 2020

Antiparkinsonian activity of (+)-PHNO in the MPTP-treated common marmoset

1 reference

12 December 2020

Open pilot trial of ritanserin in parkinsonism.

1 reference

12 December 2020

Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding.

1 reference

12 December 2020

The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset

1 reference

12 December 2020

Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism.

1 reference

12 December 2020

Dopaminergic mechanisms in hemiparkinsonian monkeys

1 reference

12 December 2020

Antiparkinsonian activity of a single oral dose of PHNO

1 reference

12 December 2020

Differential projections of neurons within the dorsal raphe nucleus of the rat: a horseradish peroxidase (HRP) study

1 reference

12 December 2020

Problems of levodopa treatment.

1 reference

12 December 2020

Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.

1 reference

12 December 2020

Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.

1 reference

12 December 2020

Behavioural effects of (+)-4-propyl-9-hydroxynaphthoxazine in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

12 December 2020

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

1 reference

12 December 2020

Delirium and stereotypy from anticholinergic antiparkinson drugs

1 reference

12 December 2020

Alterations in motor behaviour produced by the isomers of 3-PPP in the MPTP-treated marmoset

1 reference

12 December 2020

Selective D-1 dopamine receptor agonist treatment of Parkinson's disease

1 reference

12 December 2020

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

12 December 2020

Antagonism of cortical excitation of striatal neurons by glutamic acid diethyl ester: Evidence for glutamic acid as an excitatory transmitter in the rat striatum

1 reference

12 December 2020

Distribution of 3H-methylatropine in rat brain

1 reference

12 December 2020

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.

1 reference

12 December 2020

Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02244093

1 reference

Dimensions Publication ID

10 December 2017

0 references

1 reference